EMD Serono is proud to announce that the U.S. Food and Drug Administration (FDA) has approved Rebif® Rebidose® (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS). The approval of Rebif Rebidose underscores our longstanding commitment to the MS community and our investment in the development of delivery devices to meet the needs of those living with MS.

• Press Release
• Learn more about Rebif®

Want to know where and why EMD Serono employees are volunteering their time? Or would you like to get a more personal view of EMD Serono?

• Join us on Facebook

EMD Serono's YouTube channel offers interviews with employees and business partners, therapeutic area insights, as well as corporate news.

• Watch EMD Serono on YouTube

Learn more about corporate news, employee initiatives, and industry related events by following EMD Serono on Twitter.

• Learn more about EMD Serono on Twitter

EMD Serono will donate to The One Fund for every Boston win this baseball season. Join us in contributing to those affected by the Marathon Bombings.

• Donate

MS LifeLines’ Call Center has been recognized by J.D. Power and Associates for providing "An Outstanding Customer Service Experience" to the MS Community

• Press Release

Over the past 10 years, EMD Serono, Inc. and Pfizer Inc. have continued to develop and expand numerous programs that provide MS education and support to people living with MS and the greater MS community. View a timeline of key events from the past decade of dedication to the MS community:

• Timeline

EMD Serono's Office of Government Affairs has been awarded the RESOLVE: The National Infertility Association's Hope Award for Advocacy for its support for patient advocacy, access to care and RESOLVE's advocacy agenda.

• Awards and Recognition

EMD Serono, Inc. has an ongoing commitment to improving the entire patient experience. To this end, we offer comprehensive patient education resources across all of our therapeutic areas of focus.

• Learn more about our Therapeutic Areas and Patient Resources
• Watch more videos on our YouTube channel

Dr. Thorsten Eickenhorst, Senior Vice President and Chief Medical Officer: Innovation and progress is seldom based on the genius of a single individual, but the result of cross-fertilization of ideas in motivated teams based on diverse backgrounds and experience. EMD Serono provides this environment of cooperation and collaboration in the context of a long term corporate strategy. We have the unique opportunity to focus on excellence in delivering innovative medicines to patients in need.

• Breakthrough Innovations
• Pipeline

Evan Lippman, Senior Vice President, Neurodegenerative Diseases and Rheumatology: Senior Leadership actively supports a culture of creating positive change, enabling innovators to experiment and challenge the status quo. Everyone engages, pulls together, helps draw connections between complex thoughts, tears a situation apart and puts it back together in a way that is new and exciting.

• Commitment
• Leadership Team